Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review

Autores da FMUP
Participantes de fora da FMUP
- Figueiredo, R
- Adao, R
Unidades de investigação
Abstract
Background: Heart failure (HF) is a high prevalent syndrome with significant burden worldwide. B-type natriuretic peptide (BNP) and N-terminal proBNP are the gold standard biomarkers in HF management. Although useful in clinical practice, they have limitations as their expression can be influenced by ventricular function, aging, obesity, renal failure and atrial arrhythmias. MicroRNAs have recently emerged as potential diagnostic and prognostic biomarkers, given that they are related to cell growth, proliferation, differentiation, and metabolism. An increas-ing amount of research has highlighted some microRNAs for their potential as HF biomarkers. However, different study designs, methods and study groups have led to inconsistent results.Methods and results: We performed a systematic search of available literature on Pubmed and Scopus reporting the prognostic value of microRNAs in HF, followed by a review of risk of bias, according to Quadas Group Standards. Simultaneously, microRNAs' potential as differential diag-nosis and severity biomarkers was also analyzed. Studies have described circulating microRNA as potential diagnostic, prognostic, and severity markers. Mir-622,-519 and-499 were signifi-cantly related to HF with reduced ejection fraction, whereas miR-22-3p revealed greater ability as a severity biomarker. Let-7i-5p, miR-223-5p, miR-423-5p, miR-21, miR-1306-5p and miR-122 serum expressions presented a consistent correlation with HF prognosis. Furthermore, identi-fied miR targets were associated with signaling pathways already known to be involved in HF progression.Conclusion: Several miRs were related to HF pathophysiology and demonstrated potential as biomarkers for disease progression. MicroRNAs have a promising role in HF, and although unques-tionable, we require a deeper and broader understanding of their role and function for future research.(c) 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan tilde a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Copyright © 2022 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 0870-2551, 2174-2030
- Tipo:
- Review
- Páginas:
- 865-885
- Link para outro recurso:
- www.scopus.com
Revista Portuguesa de Cardiologia Sociedade Portuguesa De Cardiologia
Citações Recebidas na Web of Science: 4
Citações Recebidas na Scopus: 8
Documentos
- Não há documentos
Filiações
Keywords
- Heart failure; Biomarkers; Prognosis; MicroRNA; Circulating microRNA
Campos de estudo
Financiamento
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Bypass) . 2020
Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Aortic Valve Replacemen) . 2020
Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Persistent Pulmonary Hypertension of the Newborn: Pathophysiological mechanisms and novel therapeutic approaches
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2020
"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
An overview of circulating pulmonary arterial hypertension biomarkers
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2022
Heart Failure with preserved ejection fraction: a pharmacotherapeutic update
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2022
Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Arrtery bypass) . 2022
Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Pthological rola of urocortin-2 in pulmonaryn hypertension - therapeutic implications
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2020
Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Figueiredo R,Adao R,Leite A,Mâncio J,Brás C. Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review. Rev Port Cardiol. 2022. 41(10):p. 865-885. IF:1,800. (4).